2-(4-Hydroxy-phenyl)-benzothiazol-5-ol

ID: ALA43722

Chembl Id: CHEMBL43722

PubChem CID: 135449054

Max Phase: Preclinical

Molecular Formula: C13H9NO2S

Molecular Weight: 243.29

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Oc1ccc(-c2nc3cc(O)ccc3s2)cc1

Standard InChI:  InChI=1S/C13H9NO2S/c15-9-3-1-8(2-4-9)13-14-11-7-10(16)5-6-12(11)17-13/h1-7,15-16H

Standard InChI Key:  GDZBRZPSSANEPO-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA43722

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 243.29

Molecular Weight (Monoisotopic): 243.0354

AlogP: 3.37

#Rotatable Bonds: 1

Polar Surface Area: 53.35

Molecular Species: NEUTRAL

HBA: 4

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 3

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 8.89

CX Basic pKa: 2.58

CX LogP: 3.53

CX LogD: 3.52

Aromatic Rings: 3

Heavy Atoms: 17

QED Weighted: 0.69

Np Likeness Score: -1.10

References

1. Stevens MF, McCall CJ, Lelieveld P, Alexander P, Richter A, Davies DE..  (1994)  Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin.,  37  (11): [PMID:8201603] [10.1021/jm00037a020]

Source

Source(1):

• Scientific Literature